Want to see JP:4577 full AI Analyst Report?
Daito Pharmaceutical Co., Ltd. (4577) Ratios
0 Followers
Daito Pharmaceutical Co., Ltd. Ratios
JP:4577's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:4577's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | May 25 | May 24 | May 23 | May 22 | May 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.62 | 2.45 | 2.24 | 2.64 | 2.69 |
| Quick Ratio | 1.44 | 1.37 | 1.11 | 1.45 | 1.50 |
| Cash Ratio | 0.07 | 0.13 | 0.15 | 0.23 | 0.31 |
| Solvency Ratio | 0.37 | 0.24 | 0.27 | 0.38 | 0.46 |
| Operating Cash Flow Ratio | 0.67 | 0.35 | 0.28 | 0.27 | 0.31 |
| Short-Term Operating Cash Flow Coverage | 2.82 | 1.90 | 2.47 | 2.77 | 3.64 |
| Net Current Asset Value | ¥ 16.28B | ¥ 15.78B | ¥ 16.02B | ¥ 21.08B | ¥ 20.64B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.15 | 0.11 | 0.07 | 0.05 |
| Debt-to-Equity Ratio | 0.18 | 0.23 | 0.17 | 0.10 | 0.07 |
| Debt-to-Capital Ratio | 0.15 | 0.19 | 0.14 | 0.09 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.11 | 0.08 | 0.06 | 0.05 |
| Financial Leverage Ratio | 1.39 | 1.50 | 1.49 | 1.39 | 1.37 |
| Debt Service Coverage Ratio | 2.06 | 1.93 | 3.21 | 4.91 | 6.44 |
| Interest Coverage Ratio | 27.98 | 21.31 | 94.98 | 433.92 | 728.11 |
| Debt to Market Cap | 0.21 | 0.32 | 0.39 | 0.29 | 0.19 |
| Interest Debt Per Share | 320.38 | 394.73 | 558.28 | 314.26 | 225.74 |
| Net Debt to EBITDA | 1.04 | 1.31 | 0.76 | 0.15 | -0.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 19.54% | 16.73% | 20.98% | 22.91% | 26.36% |
| EBIT Margin | 7.18% | 6.08% | 9.08% | 11.28% | 15.11% |
| EBITDA Margin | 15.84% | 14.64% | 16.89% | 19.86% | 22.73% |
| Operating Profit Margin | 7.18% | 5.18% | 8.30% | 11.55% | 15.08% |
| Pretax Profit Margin | 8.03% | 5.84% | 8.99% | 11.25% | 15.46% |
| Net Profit Margin | 6.24% | 3.77% | 7.03% | 7.98% | 10.74% |
| Continuous Operations Profit Margin | 6.19% | 3.49% | 6.78% | 7.82% | 10.65% |
| Net Income Per EBT | 77.76% | 64.50% | 78.12% | 70.92% | 69.46% |
| EBT Per EBIT | 111.77% | 112.86% | 108.32% | 97.48% | 102.55% |
| Return on Assets (ROA) | 4.31% | 2.45% | 4.24% | 5.10% | 7.19% |
| Return on Equity (ROE) | 5.98% | 3.67% | 6.33% | 7.10% | 9.87% |
| Return on Capital Employed (ROCE) | 6.13% | 4.30% | 6.58% | 9.45% | 12.88% |
| Return on Invested Capital (ROIC) | 4.48% | 2.43% | 4.76% | 6.39% | 8.67% |
| Return on Tangible Assets | 4.42% | 2.46% | 4.27% | 5.13% | 7.23% |
| Earnings Yield | 9.24% | 6.37% | 18.87% | 21.75% | 25.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.67 | 2.50 | 3.04 | 2.55 | 2.69 |
| Payables Turnover | 5.49 | 5.10 | 4.26 | 7.84 | 7.12 |
| Inventory Turnover | 2.48 | 2.29 | 1.77 | 1.91 | 1.90 |
| Fixed Asset Turnover | 1.65 | 1.59 | 1.47 | 1.75 | 1.88 |
| Asset Turnover | 0.69 | 0.65 | 0.60 | 0.64 | 0.67 |
| Working Capital Turnover Ratio | 2.14 | 2.13 | 1.95 | 1.84 | 2.00 |
| Cash Conversion Cycle | 217.40 | 233.80 | 240.26 | 287.77 | 276.17 |
| Days of Sales Outstanding | 136.60 | 145.98 | 120.18 | 142.87 | 135.59 |
| Days of Inventory Outstanding | 147.23 | 159.37 | 205.77 | 191.45 | 191.82 |
| Days of Payables Outstanding | 66.43 | 71.55 | 85.68 | 46.56 | 51.24 |
| Operating Cycle | 283.83 | 305.34 | 325.95 | 334.33 | 327.41 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 318.79 | 193.85 | 330.25 | 262.73 | 285.44 |
| Free Cash Flow Per Share | 187.93 | -31.46 | -69.72 | -88.59 | -23.71 |
| Dividend Paid and CapEx Coverage Ratio | 1.89 | 0.75 | 0.72 | 0.64 | 0.81 |
| Capital Expenditure Coverage Ratio | 2.44 | 0.86 | 0.83 | 0.75 | 0.92 |
| Operating Cash Flow Coverage Ratio | 1.01 | 0.50 | 0.59 | 0.84 | 1.27 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.12 | 0.11 | 0.09 | 0.10 |
| Free Cash Flow Yield | 16.16% | -3.19% | -6.26% | -8.46% | -1.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.82 | 15.70 | 5.30 | 4.60 | 3.90 |
| Price-to-Sales (P/S) Ratio | 0.68 | 0.59 | 0.37 | 0.37 | 0.42 |
| Price-to-Book (P/B) Ratio | 0.65 | 0.58 | 0.34 | 0.33 | 0.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.19 | -31.31 | -15.96 | -11.82 | -50.17 |
| Price-to-Operating Cash Flow Ratio | 3.65 | 5.08 | 3.37 | 3.98 | 4.17 |
| Price-to-Earnings Growth (PEG) Ratio | 0.15 | -0.39 | -0.68 | -0.18 | 0.50 |
| Enterprise Value Multiple | 5.30 | 5.35 | 2.96 | 2.00 | 1.75 |
| Enterprise Value | 42.55B | 39.64B | 23.46B | 17.91B | 17.28B |
| EV to EBITDA | 5.30 | 5.35 | 2.96 | 2.00 | 1.75 |
| EV to Sales | 0.84 | 0.78 | 0.50 | 0.40 | 0.40 |
| EV to Free Cash Flow | 7.70 | -41.42 | -21.44 | -12.78 | -47.60 |
| EV to Operating Cash Flow | 4.54 | 6.72 | 4.53 | 4.31 | 3.95 |
| Tangible Book Value Per Share | 1741.68 | 1694.22 | 3299.60 | 3199.18 | 3088.54 |
| Shareholders’ Equity Per Share | 1798.15 | 1709.44 | 3318.40 | 3204.11 | 3089.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.40 | 0.25 | 0.31 | 0.31 |
| Revenue Per Share | 1721.93 | 1664.74 | 2988.66 | 2851.84 | 2838.97 |
| Net Income Per Share | 107.46 | 62.72 | 209.99 | 227.64 | 304.90 |
| Tax Burden | 0.78 | 0.65 | 0.78 | 0.71 | 0.69 |
| Interest Burden | 1.12 | 0.96 | 0.99 | 1.00 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.05 | 0.05 | 0.04 | 0.04 |
| SG&A to Revenue | 0.12 | 0.07 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.97 | 3.09 | 1.23 | 0.82 | 0.65 |
Currency in JPY
